Galderma Group AG
Status: Publicly traded
Direct answer
Galderma Group AG is publicly traded on SIX under the ticker GALD.SW.
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte,...
Can you invest in Galderma Group AG?
Yes. Galderma Group AG is publicly traded on SIX under the ticker GALD.SW.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Galderma Group AG
Detailed equity research is provided by MarketSnap.